Dilemmas in the management of syphilis: A survey of infectious diseases experts

Clinical Infectious Diseases

Volumn 49, Issue 10, 2009, Pages 1526-1529

  Dowell, Deborah ^a   Polgreen, Philip M ^c   Beekmann, Susan E ^c   Workowski, Kimberly A ^a,b   Berman, Stuart M ^a   Peterman, Thomas A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; PENICILLIN G;

ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL PRACTICE; DIAGNOSTIC TEST; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYPHILIS;

ATTITUDE OF HEALTH PERSONNEL; CASE MANAGEMENT; GUIDELINES AS TOPIC; HEALTH SERVICES; HIV INFECTIONS; HUMANS; PHYSICIANS; SPECIALIZATION; SYPHILIS;

EID: 72849114396     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644737     Document Type: Article

References (15)

1. Workowski KA, Berman SM; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55(RR-11):1-94
2. erratum: MMWR Recomm Rep 2006; 55:997.
3. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986; 104:368-376 (Pubitemid 16163620)
4. Musher DM, Baughn RE. Neurosyphilis in HIV-infected persons. N Engl J Med 1994; 331:1516-1517
5. Symptomatic early neurosyphilis among HIV-positive men who have sex with men--four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007; 56:625-628
6. Marra CM, Maxwell CL, Tantalo LC, Sahi SK, Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47:893-899
7. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997; 337:307-314
8. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83:97-101.
9. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008; 47:258-265
10. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network. The emerging infections network: a new venture for the Infectious Diseases Society of America. Clin Infect Dis 1997; 25:34-36
11. Eccleston K, Collins L, Higgins SP. Primary syphilis. Int J STD AIDS 2008; 19:145-151
12. Chapel TA, Brown WJ, Jeffries C, Stewart JA. How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis 1977; 4: 150-152
13. OFarrell N, Hoosen AA, Coetzee KD, van den Ende J. Genital ulcer disease: accuracy and clinical diagnosis and strategies to improve control in Durban, South Africa. Genitourin Med 1994; 70:7-11.
14. DiCarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997; 25:292-298 (Pubitemid 127775487)
15. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2009; 58:1-198.